These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10607876)

  • 21. Effect of mineralocorticoid activity on transtubular potassium gradient, urinary [K]/[Na] ratio, and fractional excretion of potassium.
    Chacko M; Fordtran JS; Emmett M
    Am J Kidney Dis; 1998 Jul; 32(1):47-51. PubMed ID: 9669423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central administration of zinc increases renal sodium and potassium excretion in rats.
    De Castro-e-Silva E; Luz CP; Marinho CA; Castro L; Sarmento C; Gonzalez V; Oliveira P; Nascimento T; Santana P; Lima AK; Fregoneze JB
    Brain Res; 1999 Oct; 845(2):176-84. PubMed ID: 10536196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central interactions between aldosterone and vasopressin on cardiovascular system.
    Janiak P; Brody MJ
    Am J Physiol; 1988 Jul; 255(1 Pt 2):R166-73. PubMed ID: 2839996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term effects of intracerebroventricular insulin microinjection on renal sodium handling and arterial blood pressure in rats.
    Menegon LF; Zaparolli A; Boer PA; de Almeida AR; Gontijo JA
    Brain Res Bull; 2008 Jul; 76(4):344-8. PubMed ID: 18502308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mineralocorticoid receptors mediate cardiac remodelling in morphine-dependent rats.
    Mesripour A; Iyer A; Brown L
    Basic Clin Pharmacol Toxicol; 2012 Aug; 111(2):75-80. PubMed ID: 22304485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of spironolactone and captopril on nitric oxide and S-nitrosothiol formation in kidney of L-NAME-treated rats.
    Pechanova O; Matuskova J; Capikova D; Jendekova L; Paulis L; Simko F
    Kidney Int; 2006 Jul; 70(1):170-6. PubMed ID: 16710350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mineralocorticoid receptor blockade and calcium channel blockade have different renoprotective effects on glomerular and interstitial injury in rats.
    Du J; Fan YY; Hitomi H; Kiyomoto H; Kimura S; Kong CZ; Noma T; Kohno M; Nishiyama A; Nakano D
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F802-8. PubMed ID: 19535572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spironolactone ameliorates arterial medial calcification in uremic rats: the role of mineralocorticoid receptor signaling in vascular calcification.
    Tatsumoto N; Yamada S; Tokumoto M; Eriguchi M; Noguchi H; Torisu K; Tsuruya K; Kitazono T
    Am J Physiol Renal Physiol; 2015 Dec; 309(11):F967-79. PubMed ID: 26336165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective cardiorenal effects of spironolactone in a rodent model of polycystic kidney disease.
    Jeewandara TM; Ameer OZ; Boyd R; Wyse BF; Underwood CF; Phillips JK
    Clin Exp Pharmacol Physiol; 2015 Apr; 42(4):353-60. PubMed ID: 25676668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and prevents oxidative stress in uremic rats.
    Michea L; Villagrán A; Urzúa A; Kuntsmann S; Venegas P; Carrasco L; Gonzalez M; Marusic ET
    Hypertension; 2008 Aug; 52(2):295-300. PubMed ID: 18591458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a simplified assay for determination of the antimineralocorticoid activity of compounds dosed in rats.
    Brandish PE; Chen H; Szczerba P; Hershey JC
    J Pharmacol Toxicol Methods; 2008; 57(2):155-60. PubMed ID: 18304838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypotensive effects of intravenously administered uridine and cytidine in conscious rats: involvement of adenosine receptors.
    Yilmaz MS; Coskun C; Suzer O; Yalcin M; Mutlu D; Savci V
    Eur J Pharmacol; 2008 Apr; 584(1):125-36. PubMed ID: 18313046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of eplerenone on heart and kidney in two-kidney, one-clip rats.
    Hao L; Kanno Y; Fukushima R; Watanabe Y; Ishida Y; Suzuki H
    Am J Nephrol; 2004; 24(1):54-60. PubMed ID: 14707436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cooperative Role of Mineralocorticoid Receptor and Caveolin-1 in Regulating the Vascular Response to Low Nitric Oxide-High Angiotensin II-Induced Cardiovascular Injury.
    Pojoga LH; Yao TM; Opsasnick LA; Siddiqui WT; Reslan OM; Adler GK; Williams GH; Khalil RA
    J Pharmacol Exp Ther; 2015 Oct; 355(1):32-47. PubMed ID: 26183312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Marinobufagenin in Urine: A Potential Marker of Predisposition to Ethanol and a Target for Spironolactone.
    Kashkin VA; Shekunova EV; Egorov AY; Bagrov AY
    Curr Hypertens Rev; 2018; 14(1):35-38. PubMed ID: 29437012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of mineralocorticoid receptor on experimental cerebral aneurysms in rats.
    Tada Y; Kitazato KT; Tamura T; Yagi K; Shimada K; Kinouchi T; Satomi J; Nagahiro S
    Hypertension; 2009 Sep; 54(3):552-7. PubMed ID: 19620512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 11-Dehydrocorticosterone in the presence of carbenoxolone is a more potent sodium retainer than corticosterone.
    Souness GW; Morris DJ
    Steroids; 1993 Jan; 58(1):24-8. PubMed ID: 8430442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucocorticoid and mineralocorticoid receptors are involved in the facilitation of anxiety-like response induced by restraint.
    Calvo N; Volosin M
    Neuroendocrinology; 2001 Apr; 73(4):261-71. PubMed ID: 11340340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus.
    Guo C; Martinez-Vasquez D; Mendez GP; Toniolo MF; Yao TM; Oestreicher EM; Kikuchi T; Lapointe N; Pojoga L; Williams GH; Ricchiuti V; Adler GK
    Endocrinology; 2006 Nov; 147(11):5363-73. PubMed ID: 16901964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a new mineralocorticoid antagonist mespirenone on aldosterone-induced hypertension.
    Opoku J; Kalimi M; Agarwal M; Qureshi D
    Am J Physiol; 1991 Feb; 260(2 Pt 1):E269-71. PubMed ID: 1996630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.